Positron Corporation POSC
Rating
Rating Factors
Company Overview
Positron Corporation (OTC: POSC) is a U.S.-based medical technology company historically focused on nuclear imaging systems and healthcare diagnostic technologies, particularly positron emission tomography (PET) imaging solutions used in cardiology and oncology applications. The company has operated within the broader healthcare equipment and medical imaging industry, with activities centered on diagnostic imaging hardware, related services, and healthcare technology commercialization. Public disclosures and historical filings indicate that the company’s core business has included the development, marketing, and servicing of PET imaging systems designed for hospitals, outpatient imaging centers, and specialty diagnostic providers.
The company evolved through multiple strategic shifts over its operating history, including efforts to expand beyond imaging hardware into healthcare technology and ancillary medical services. Historical public filings reference products and operations connected to cardiac PET imaging and molecular imaging technologies. Available public information suggests that Positron sought to differentiate itself by focusing on specialized PET imaging solutions intended to provide lower-cost alternatives within cardiac imaging workflows. However, recent operational scale, active revenue generation, and commercial traction are difficult to independently verify through current public disclosures. Data inconclusive based on available public sources.
Income Statement
Balance Sheet
Cash Flow
Filings
Price History
- Low
- $1.27
- Current
- $1.84
- High
- $2.74
Valuation
Dividends and Shares
Corporate Info
Suite 100
North Tonawanda, NY 14120